BioSpace News Archive

Following its regularly scheduled meeting, the Board of Directors of Pfizer Inc. announced that Executive Chairman of the Board Ian C. Read has chosen to retire on December 31, 2019, and that it has unanimously elected Pfizer’s Chief Executive Officer (CEO), Dr. Albert Bourla, to succeed him as Chairman of the Board of Directors effective January 1, 2020.

Results from the second interim analysis of the Phase 3 SPARTAN study featured in an oral presentation at ESMO 2019 and simultaneously published in Annals of Oncology

Searchlight Pharma is pleased to announce that it has been named to The Globe and Mail’s inaugural Report on Business ranking of Canada’s Top Growing Companies.

The global asthma spacers market size is poised to grow by USD 297.72 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of over 4% during the forecast period.

Bactiguard has entered into an exclusive, global license agreement for orthopedic trauma implants with Zimmer Biomet.

Company to introduce new All In One solutions portfolio at SIIA Conference; designed to cut facility medical claims by up to 70%

22NW, LP is one of the largest shareholders of Catalyst Biosciences, Inc with ownership of approximately 6% of the Company’s outstanding shares.

Use of hēRo3℠ Platform by Drug Pricing Watchdog Following Conclusion of Pilot Transparency Initiative Confirms ICER’s Commitment to Cloud-Based Tools